Publikationen von Ramin Massoumi

Chu, Y.; Soberon, V.; Glockner, L.; Beyaert, R.; Massoumi, R.; van Loo, G.; Krappmann, D.; Schmidt-Supprian, M.: A20 and CYLD Do Not Share Significant Overlapping Functions during B Cell Development and Activation. JOURNAL OF IMMUNOLOGY 189 (9), S. 4437 - 4443 (2012)

Liang, G.; Ahlqvist, K.; Pannem, R.; Posern, G.; Massoumi, R.: Serum Response Factor Controls CYLD Expression via MAPK Signaling Pathway. PLoS ONE 6 (5), e19613, S. [1] - [12] (2011)

Kuphal, S.; Massoumi, R.; Haas, B.; Wild, P. J.; Spruss, T.; Pfeifer, A.; Bosserhoff, A. K.: Persistent NFkappaB activation in malignant melanoma is generated through loss of the tumor suppressor CYLD. Experimental Dermatology 19 (2), P 258, S. 209 - 209 (2010)

Wickström, S. A.; Masoumi, K. C.; Khochbin, S.; Fässler, R.; Massoumi, R.: CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin. EMBO Journal 29 (1), S. 131 - 144 (2010)

Urbanik, T.; Heine, S.; Worns, M.; Hovelmeyer, N.; Boger, R. J.; Maass, T.; Massoumi, R.; Fässler, R.; Schuchmann, M.; Galle, P. R. et al.; Waisman, A.; Schulze-Bergkamen, H.: CYLD: A KEY REGULATOR OF HEPATOCELLULAR APOPTOSIS, PROLIFERATION AND CARCINOGENESIS. Journal of Hepatology 52 (Suppl. 1), S. S32 - S33 (2010)

Massoumi, R.; Kuphal, S.; Hellerbrand, C.; Haas, B.; Wild, P.; Spruss, T.; Pfeifer, A.; Fässler, R.; Bosserhoff, A. K.: Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma. Journal of Experimental Medicine 206 (1), S. 221 - 232 (2009)

Hovelmeyer, N.; Reissig, S.; Massoumi, R.; Fässler, R.; Waisman, A.: The involvement of the tumor suppressor gene Cyld in autoimmune brain inflammation. Wiener Klinische Wochenschrift 120 (Suppl. Suppl. 1), S. 156 - 156 (2008)

Hovelmeyer, N.; Wunderlich, F. T.; Massoumi, R.; Jakobsen, C. G.; Song, J.; Worns, M. A.; Merkwirth, C.; Kovalenko, A.; Aumailley, M.; Strand, D. et al.; Bruning, J. C.; Galle, P. R.; Wallach, D.; Faessler, R.; Waisman, A.: Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD. Journal of Experimental Medicine 204 (11), S. 2615 - 2627 (2007)

Moriwaki, K.; Tsuruta, D.; Sugawara, K.; Kobayashi, H.; Massoumi, R.; Ishii, M.: A role of CYLD in hair cycling mouse. Journal of Investigative Dermatology 127 (Suppl. Suppl. 1), S. S107 - S107 (2007)

Hellerbrand, C.; Bumes, E.; Bataille, F.; Dietmaier, W.; Massoumi, R.; Bosserhoff, A. K.: Reduced expression of CYLD in human colon and hepatocellular carcinomas. Carcinogenesis 28 (1), S. 21 - 27 (2007)

Massoumi, R.; Chmielarska, K.; Hennecke, K.; Pfeifer, A.; Fässler, R.: Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-κB signaling. Cell 125 (4), S. 665 - 677 (2006)

Massoumi, R.; Podda, M.; Fässler, R.; Paus, R.: Cylindroma as tumor of hair follicle origin. Journal of Investigative Dermatology 126 (5), S. 1182 - 1184 (2006)

Chu, Y.; Soberon, V.; Beyaert, R.; Massoumi, R.; van Loo, G.; Schmidt-Supprian, M.: The deubiquitinases A20 and CYLD do not share overlapping functions during B cell differentiation and activation. In Immunology, 137 (Suppl. 1 Sp. Iss.), S. 340 - 340. WILEY-BLACKWELL, HOBOKEN (2012)